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Objectives: Systemic right ventricular failure after atrial switch procedures for
transposition of the great arteries has been addressed at Melbourne’s Royal Chil-
dren’s Hospital (1981-1993) and the Cleveland Clinic Foundation (1993-2001) with
reconditioning of the morphologically left ventricle by means of pulmonary artery
banding followed by an arterial switch operation and an atrial reseptation.
Methods: Thirty-nine patients (Royal Children’s Hospital, 19; Cleveland Clinic
Foundation, 20) with a median age of 10.8 years (range, 13 months24 years)
entered this protocol a median of 10.3 years (range, 0.5-24 years) after an atrial
switch procedure.
Results: The median duration of pulmonary artery banding was 13 months (range,
0.5-5.4 years). Ten (28%) patients responded unfavorably to morphologically left
ventricular reconditioning (5 mortalities: 4 transplantations and 1 PAB still in
place). Twenty-four (83%) of the 29 patients who underwent an atrial switch
operation and atrial reseptation survived. During a median follow-up period of 8.2
years (range, 1-16 years), 3 patients had cardiac-related deaths. All 18 long-term
survivors are asymptomatic. At last echocardiographic evaluation, the morphologically
left ventricular function was normal or mildly decreased in 16 (89%) patients, and all
had normal or mildly decreased systemic right ventricular function with no or mild
tricuspid regurgitation. Age greater than 12 years was associated with a greater proba-
bility of morphologically left ventricular failure and not completing the protocol
(P  .02) and a higher operative mortality at anatomic correction (P  .02).
Conclusions: Morphologically left ventricular reconditioning and an anatomic cor-
rection protocol should be integrated into a cardiac transplantation program when
treating patients with morphologically right ventricular failure after Mustard and
Senning procedures. It is an alternative to cardiac transplantation in selected
patients, with good long-term results. The response to morphologically left ventric-
ular reconditioning past adolescence is inconsistent.
Atrial switch, namely the Senning and Mustard procedures, was thetreatment of choice for transposition of the great arteries (TGA)until the arterial switch operation (ASO) gained acceptance in the1980s. The major disadvantage of the atrial switch procedures isthat the morphologically right ventricle (mRV) remains the sys-temic ventricle. The systemic right ventricle fails with time and is
rated severe in approximately 10% of patients 10 years after surgical intervention.1,2
mRV failure is a risk factor for late death in this patient population.3,4 Many of these
patients are currently entering their third decade, and the prevalence of mRV failure
can be expected to increase.
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At the Royal Childrens’ Hospital (RCH), a morpholog-
ically left ventricle (mLV) retraining and anatomic correc-
tion protocol was developed by the senior author and pub-
lished in 1986.5 The protocol reintroduces the mLV into the
systemic circulation and places the mRV in the pulmonary
circuit, alleviating the strain of the systemic circulation on
the mRV and resulting in improved mRV function and
regression of tricuspid regurgitation (TR). Because the
mLV rapidly decreases in mass shortly after birth, it be-
comes incapable of supporting systemic circulation unless
there is persistent pulmonary hypertension or mLV outflow
tract obstruction that mimics the afterload of the systemic
circuit. The mLV is first retrained to maintain systemic
pressures by means of pulmonary artery banding (PAB),
which increases mLV afterload. Once the mLV can provide
systemic pressure, an anatomic correction is performed that
consists of an atrial baffle takedown, an atrial septum re-
construction, and an ASO. Cardiac transplantation has been
integrated into the treatment protocol since 1988. The lack
of donor hearts still claiming the lives of 20% to 30% of
patients on both adult and pediatric transplantation waiting
lists and the annual mortality rate of approximately 2.5%
per year during the first 10 years after transplantation6 were
additional motivations to further perfect this protocol.
Since 1981, at the RCH (1981-1993) and the Cleveland
Clinic Foundation (CCF; 1993-2002), a PAB and anatomic
correction protocol has been offered to patients with pro-
gressive and symptomatic mRV dysfunction. Patients ex-
cluded from this protocol and eventual transplantation can-
didates have irreversible mLV dysfunction, pulmonary
valve abnormalities rendering it unsuitable as a neoaortic
valve, mLV outflow tract obstruction that cannot be ade-
quately relieved, and uncontrolled arrhythmia.
The aim of this work is 4-fold: (1) report our results with
this protocol; (2) establish which patients are more likely to
respond favorably to mLV retraining and anatomic correc-
tion; (3) define the role of PAB as a sole treatment modality;
and (4) determine the place for this protocol in 2002 with
the majority of the atrial baffle population now older than 20
years.
Patients and Methods
Patients
A total of 39 patients, 19 from the RCH and 20 from the CCF,
including 20 male and 19 female subjects, entered the mLV
retraining and anatomic correction protocol. The median age at the
beginning of the protocol was 10.3 years (range, 0.5-24 years;
mean, 10.7  5.3 years), with 24 (62%) patients aged less than 12
years and 15 patients (38%) older than 12 years. The patients were
significantly older in the CCF group (RCH median, 9.2 years
[range, 0.6-16.1 years); CCF median, 13.9 years [range, 2.1-24
years]; P  .007). Their initial diagnosis was TGA with a ven-
tricular septal defect in 21 (54%) patients, TGA with an intact
septum in 12 (31%) patients, and Taussig-Bing in 6 (15%) pa-
tients. An atrial switch procedure had been practiced a median of
9 years (range, 0.2-22 years; mean, 9.7  5.4 years) beforehand:
a Senning procedure in 22 (56%) patients and a Mustard operation
in 17 (44%) patients. The majority (82%) of the patients were in
New York Heart Association (NYHA) functional class 2, with 7
(18%) patients in NYHA functional class 3. Twelve (31%) patients
had supraventricular arrhythmias, including 3 with a permanent
pacemaker.
Cardiac transplantation began in 1988 at the RCH. Eleven
(58%) of the 19 patients operated on at the RCH were entered into
the mLV retraining and anatomic correction protocol before the
establishment of the cardiac transplantation program. Of the 20
patients treated at the CCF, 4 (20%) were not transplant candi-
dates.
Preprotocol cardiac catheterization was performed in all 39
patients. Four patients (ages 2.2, 10.8, 16.5, and 20 years) with
mLV outflow tract obstruction (n  2) or pulmonary hypertension
caused by atrial baffle obstruction (n  2) had an mLV capable of
generating systemic pressures (100, 90, 98, and 84 mm Hg), and
therefore an anatomic correction was performed without prelimi-
nary PAB. All 4 patients had mild or moderate mRV dysfunction
and TR with a normally functioning mLV and no mitral regurgi-
tation (MR) documented by means of echocardiography.
The remaining 35 (90%) patients had mLV systolic pressures
(mLVPs) that could not sustain systemic pressures with median
mLVPs of 34 mm Hg (range, 17-65 mm Hg; mean, 36.4 13 mm
Hg) and a median ratio of the mLV and mRV systolic pressures of
0.30 (range, 0.18-0.6; mean, 0.35  0.11). Preprotocol echocar-
diographic evaluation of these patients showed severe mRV dys-
function in 9 (26%) patients, moderate dysfunction in 22 (63%)
patients, and mild dysfunction in 4 (11%) patients. Concomitant
TR was severe in 13 (37%) patients and moderate in 17 (48%)
patients. Mild TR with moderate-to-severe mRV dysfunction was
observed in 5 (14%) patients. All patients with mild mRV dys-
function had severe TR. Moderate mLV dysfunction was observed
in 1 patient, and mild dysfunction was observed in 2 patients,
including one with moderate MR. Fourteen patients evaluated after
1995 underwent pre-PAB cardiac magnetic resonance imaging
(MRI). The median mLV indexed mass was 52.5 g/m2 (range,
31-105 g/m2; mean, 55  19 g/m2), with the normal value being
greater than 80 g/m2.
Protocol
Details of the treatment protocol and surgical technique, including
illustrations, can be found in previous publications.7-9 A few
important points of the protocol are outlined below.
PAB. Invasive monitoring includes a Swan-Ganz catheter in
patients heavier than 15 kg to record mLV pressures during PAB.
It is floated into the mLV, and the balloon is kept inflated and
positioned in the middle of the mLV cavity, thus avoiding arrhyth-
mias induced by the catheter. Through a median sternotomy, the
band is applied and tightened until the systemic blood pressure
decreases and the central venous pressure increases, achieving a
20- to 50-mm-Hg mLV pressure increase. A transesophageal echo-
cardiograph documents the effects of the PAB on mRV and mLV
size and function, septal position, and tricuspid valve function. A
shift in the interventricular septum with an increase in mLV
pressures and reduction of the TR and mRV dysfunction are
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sought. A tight band can reduce mLV function, decrease the
contractility of the mLV, and induce MR. Dopamine (2.5-5 g ·
kg1 · min1) or dobutamine (2.5-5 g · kg1 · min1) is started
on leaving the operating room and continued for the first 5 days of
mLV retraining. On the first postoperative day, digoxin and di-
uretics are started, and if the mLV function remains good on
control transthoracic echocardiography (TTE), the patient is extu-
bated. One week after banding, after discontinuation of dopamine,
a TTE is repeated, and MRI is used to evaluate ejection fraction
and ventricular mass. Myocardial hypertrophy caused by cellular
edema identified at T2-weighted MRI analysis is a probable sign of
myocardial damage and might result in late scarring and mLV
dysfunction. A cardiac catheterization is also performed before
discharge to evaluate ventricular pressures. If there is any evidence
of mLV failure, the pulmonary artery band is loosened immedi-
ately. If the mLV pressure has decreased since the operation and
there is no sign of mLV compromise, the pulmonary artery band is
tightened during the same hospitalization.
mLV function and pressures are assessed every 3 months by
means of TTE and by means of cardiac catheterization every 6
months. Before the switch conversion, a TTE, a cardiac catheter-
ization, and MRI are performed to determine whether anatomic
correction is feasible. The mLV must function normally, generat-
ing greater than 80% systemic blood pressures and suprasystemic
pressures with the administration of isoproterenol. The MRI eval-
uation, echocardiographic evaluation, or both should show normal
ventricular mass and ventricular wall thickness indexed for weight
and age. If these criteria are not met, PAB is repeated. If mLV
dysfunction is observed, PAB is not tolerated, or both, patients are
listed for transplantation if they are in end-stage heart failure, have
deteriorating functional class, and have a limited life expectancy.
Anatomic correction. Technical details of the arterial switch,
Mustard-Senning takedown, and atrial septum reconstruction are
illustrated in previous reports.7-9
Postoperatively, the mLV function is optimized with aggressive
afterload reduction by using phenoxybenzamine (0.5 mg/kg every
8 hours), nitroprusside, or both during the immediate postoperative
period. Dopamine, dobutamine, milrinone, or a combination of
these agents is added to further improve cardiac output. Nitroglyc-
erin (0.5-5.0 g · kg1 · min1) is administered to prevent coro-
nary vasospasm. Chronic oral afterload reduction is begun once the
patient is extubated. Biventricular function is monitored with serial
TTE perioperatively and periodically after discharge.
Statistical Methods
Clinical and follow-up data were retrieved from medical records.
Statistical analysis was obtained with Instat 3.05 software (Graph-
pad Software, Inc, San Diego, Calif). Early postoperative death
was defined as occurring within 30 days of a procedure or during
the same hospitalization. The data are reported as a medians,
ranges, and means  SD.
The significance of continuous variables on early mortality was
determined by means of the Mann-Whitney rank sum test. Cate-
goric variables were analyzed with the use of a 2 test or a Fisher
exact 2-tailed test if one of the numerators of the proportion was
equal to or less than 5 events.
Results
For the 35 patients who underwent mLV retraining, this was
achieved after a median of 2 PAB procedures. A single PAB
procedure was required in 15 (43%) patients; however,
multiple bandings were necessary in 20 patients (2 PAB
procedures, 6 patients; 3 PAB procedures, 8 patients; 4 PAB
procedures, 5 patients; 5 PAB procedures, 1 patient). Fifteen
(43%) patients underwent repeat interventions immediately
after initial PAB: 13 were tightened, and 2 were loosened.
The median duration of mLV retraining was 13 months
(range, 0.5-65 months; mean, 20.3  17 months). Eighteen
(51%) patients improved their mRV function, TR, or both.
Function remained unchanged in 15 (43%) patients and
deteriorated in 2 (6%) patients.
The clinical course after PAB is outlined in Figure 1.
Early postoperative mortality after PAB was 3% (1/39). The
only early postoperative death was a 6-month-old child with
severe TR and mRV dysfunction after a Senning procedure
who underwent a PAB with a concomitant tricuspid valve
replacement before cardiac transplantation was available in
Melbourne in 1988. There were 4 late deaths, 2 of which
were also before 1988 and occurred in patients with severe
mRV failure who did not tolerate PAB. Another patient with
a significant baffle leak and obstruction was debanded im-
mediately postoperatively because of hemodynamic insta-
bility. The family later refused transplantation, and he died
2 months later from progressive mRV dysfunction and TR.
Another child died 2 months after PAB of ventricular tachy-
cardia. Cardiac transplantation was performed in 4 patients
who presented with mLV dysfunction 2 months to 4 years
after PAB. One patient with initial moderate mRV dysfunc-
tion and TR has been banded for 5.5 years and remains
asymptomatic, with only mild mRV dysfunction and TR in
addition to a normally functioning mLV. The remaining 25
(71%) patients were successfully retrained and presented for
ASO and atrial reseptation.
In an attempt to identify patients amenable to mLV
retraining, we examined a number of factors outlined in
Table 1. On univariate analysis, the presence of preopera-
tive arrhythmia was the only significant risk factor for failed
Figure 1. Clinical course after PAB. (Reproduced with permission
from Mee RBB. Arterial Switch Operation for RV Failure Follow-
ing Mustard and Senning Operations. In Stark J, Pacifico A,
editors: Reoperations in Cardiac Surgery. Heidelberg: Springer-
Verlag; 1989. p 217-32, copyright 1989 by Springer-Verlag.)
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retraining (P  .002). Age, the number or duration of PAB
procedures, initial mLVP, and the severity of mRV failure
were not significantly different when comparing data of
patients with successful and failed mLV retraining.
A total of 29 (74%) of the initial 39 patients underwent
ASO and atrial reseptation, including the 4 patients who did
not undergo initial PAB (Figure 2). Their median mLVP
before anatomic correction was 95 mm Hg (range, 60-160
mm Hg; mean, 96  24 mm Hg), for a median increase in
mLVP during mLV retraining of 61 mm Hg (range, 12-142
mm Hg; mean, 61  31 mm Hg). The median mLV/mRV
pressure ratio was 0.91 (range, 0.5-1.6; mean, 0.90  0.35).
At echocardiography, mRV function was severely de-
creased in 5 patients, and 24 had either mild or moderate
dysfunction. Only one patient had residual severe TR after
retraining. Moderate mLV function was seen after retrain-
ing in 3 patients, and 6 had mild mLV impairment, with
mild MR in 4 patients. Nine patients had precorrection MRI
studies, with a median mLV indexed mass of 86 g/m2
(range, 69-105 g/m2; mean, 85.8  12.2 g/m2).
The early operative mortality after ASO and atrial resep-
tation was 17% (5/29). All 5 patients were either not trans-
plant candidates (n  4) or transplantation was unavailable
(n  1). Four died of mLV failure caused by myocardial
ischemia. Autopsies were performed in 2 patients and re-
vealed patent coronary arteries but multiple small subendo-
cardial and transmural myocardial infarcts. A young adult
died after massive hemoptysis from pulmonary arterio-
venous malformations identified at autopsy. One patient had
biventricular failure, had a left ventricular assist device
implanted on postoperative day 1, and was transplanted 5
days later.
During a median follow-up period of 8.2 years (range,
1-17 years; mean, 8.3  4.8 years), 2 children with pro-
gressive biventricular failure were transplanted 1 and 2
years after anatomic correction. There were 3 late deaths, all
of progressive mLV failure. One young adult had refused
transplantation, a child died before transplantation was
available, and a third patient died 14 months postoperatively
of congestive heart failure.
The 18 long-term survivors are doing very well in
NYHA functional class 1 or 2. Thirteen (72%) patients are
in sinus rhythm, a sick sinus syndrome persists in 3 (17%)
patients, and isolated premature ventricular beats were ob-
served in 2 (11%) patients. Four patients subsequently had
aortic insufficiency, and 2 have undergone aortic valve
replacement. Three patients have dilated aortic roots and are
followed closely. Follow-up echocardiography revealed the
presence of moderate and severe mLV dysfunction in 2
patients, and the remaining 16 have no or mild mLV dys-
function. MR, TR, and mRV dysfunction was either absent
or mild in all patients.
Of the 4 patients with no prior mLV retraining, a suc-
cessful anatomic correction was performed in 2 patients:
one patient underwent transplantation after postoperative
extracorporeal membrane oxygenation support, and another
died after the operation.
Overall, of the 39 patients initially enrolled in this pro-
gram, there are 29 (74%) long-term survivors: 18 anatomic
correction survivors in NYHA functional class 1 or 2 who
were transplant free, 7 patients doing well after transplan-
tation, and 1 patient who is still banded in NYHA functional
class 1.
Variables evaluated as potential risk factors for failed
anatomic correction (postoperative death, mLV failure lead-
ing to transplantation, or both) after ASO and atrial resep-
tation are listed in Table 2. Older age significantly increased
the probability of failing anatomic correction. The oldest
patient to successfully undergo ASO and reseptation and
thus complete the protocol was 16.5 years of age. Fifteen
(62%) of the 24 patients younger than 12 years of age at the
start of the protocol successfully completed mLV retraining
and anatomic correction, whereas the success rate was sig-
nificantly less (3/15 [20%] patients) in patients older than 12
years (P  .02). The presence of arrhythmia before ana-
tomic correction was significantly higher in patients who
failed conversion (P  .02). Although the occurrence of
coronary pattern other than Yacoub type A or D did not
reach significance, 4 of the 5 early deaths after conversion
had difficult coronary anatomies (single coronary ostium off
of sinus 2, n  2; single coronary ostium off of sinus 1, n
 1; and 1 with multiple coronary ostia, n  2). Precon-
version mLVPs were significantly higher in the patients
TABLE 1. Univariate predictors of postoperative mortality
and mLV failure leading to transplantation after PAB
Variable
Mortality mLV
failure-Tx
(n  10)
Successful mLV
retraining
(n  25) P value
Age (y) 14.3 (0.6-19) 9.7 (2.1-24) .58
No. of PAB
procedures
2 (1-4) 2 (1-5) .60
Arrhythmia 7 3 .002
Era (RCH/CCF) 4/6 14/11 .47
Cardiac catheterization: Pre-PAB
mLVP (mm Hg) 36.5 (17-65) 30 (18-62) .97
mLVP/mRVP ratio 0.33 (0.18-0.5) 0.3 (0.18-0.6) 1.0
Echocardiography: Pre-PAB
Severe mRV failure 4 5 .39
Severe TR 5 8 .44
Magnetic resonance imaging: Pre-PAB
mLV massi (g/m2) 54 (42-65) 59 (36-105) .50
Continuous variables are expressed as medians (ranges). mLV, Morpho-
logically left ventricle; Tx, cardiac transplantation; PAB, pulmonary artery
banding; RCH, Royal Children’s Hospital; CCF, Cleveland Clinic Foundation,
mLVP, morphologically left ventricular systolic pressure; mRVP, morpho-
logically right ventricular systolic pressure; TR, tricuspid regurgitation;
massi, indexed ventricular mass.
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who successfully underwent anatomic correction (P  .03);
however, there was no definitive mLVP cutoff identified
that could reliably predict successful conversion. Further-
more, the presence of severe mRV dysfunction was associ-
ated with a higher failure rate (P .05), possibly because of
an inadequate increase in mLVP and thus a less important
shift in the interventricular septum. The type of atrial baffle,
concomitant procedures, the era in which the operation was
performed, and mLV indexed mass at MRI were not sig-
nificantly different between the 2 groups.
Discussion
The concept of mLV retraining for mRV failure after atrial
switch procedures was introduced close to 2 decades ago5;
however, many aspects of mLV retraining and anatomic
correction have remained elusive, and we attempted to
answer these in this work.
It is now well established that the mLV geometry influ-
ences that of the mRV, which explains the improvement of
the mRV and TR with PAB.9-13 As the mLV pressure
increases during retraining, the ventricular septum will shift
from a leftward to a midline position, and the mRV end-
diastolic and end-systolic volumes will decrease. This im-
proves tricuspid valve leaflet coaptation, decreasing TR. A
decrease in TR translates into a reduction in mRV volume
load and improved function.
PAB can act as a bridge to transplantation or delay listing
for transplantation by improving mRV function and TR. It
has proved to be safe in our patient population and by other
authors.10,13 In our cohort there were no early deaths and
only one late death caused by ventricular arrhythmia be-
cause this protocol was done in conjunction with cardiac
transplantation. In our experience PAB can be performed in
patients with severe mRV failure; however, patients with
atrial arrhythmias are less likely to respond favorably to
PAB. Other factors, namely preprotocol mLV mass and
pressure, do not reliably predict which patients will success-
fully complete mLV retraining. Progressive mLV afterload
augmentation is vital because overzealous PAB can induce
mLV failure. A reliable and adjustable PAB procedure has
yet to be described and would limit the number of interven-
tions needed to retrain the mLV.
It is clear that the response to mLV retraining and ana-
tomic conversion is inconsistent in adolescents and adults
on the basis of not only our data but also those of other
authors.8,10-12 Successful mLV retraining in our series was
less frequent in patients older than 12 years of age, although
a 16.5-year-old patient is among the long-term survivors of
the conversion protocol. This inconsistent response to mLV
retraining in older patients is an important problem because
the vast majority of patients undergoing an ASO are now
older than 20 years.
TABLE 2. Univariate predictors of postoperative mortality
and mLV failure leading to transplantation after ASO and
atrial reseptation
Variable
Mortality mLV
failure-Tx
(n  11)
Successful ASO/
reseptation
(n  18) P value
Age ASO/reseptation (y) 14.2 (6-25) 11.8 (2.2-16.5) .04
Age at PAB 13 (4.8-24) 9.3 (2.1-16.5) .05
Arrhythmia 7 3 .02
Coronary anomaly 5 6 .70
Senning-Mustard 8/3 9/9 .30
Concomitant procedures 6 6 .44
Era (RCH/CCF) 4/7 11/7 .26
Cardiac catheterization pre-ASO/reseptation
mLVP (mm Hg) 72 (60-108) 100 (60-160) .03
mLVP/mRVP ratio 0.80 (0.60-1.00) 0.92 (0.50-1.60) .09
Echocardiography pre-ASO/reseptation
Severe mRV dysfunction 4 1 .05
Severe TR 2 6 .61
Magnetic resonance imaging
LV massi (g/m2) 83 (76-86) 95 (69-105) .42
Continuous variables are expressed as medians (ranges). mLV, morpho-
logically left ventricle; ASO/reseptation, arterial switch operation and atrial
reseptation; PAB, pulmonary artery banding; RCH, Royal Children’s Hospi-
tal; CCF, Cleveland Clinic Foundation; mLVP, morphologically left ventric-
ular systolic pressure; mRVP, morphologically right ventricular systolic
pressure; mRV, morphologically right ventricle; TR, tricuspid regurgitation;
massi, indexed ventricular mass; LV, left ventricular.
Figure 2. Clinical course after anatomic correction. (Reproduced with permission from Mee RBB. Arterial Switch
Operation for RV Failure Following Mustard and Senning Operations. In Stark J, Pacifico A, editors: Reoperations
in Cardiac Surgery. Heidelberg: Springer-Verlag; 1989. p 217-32, copyright 1989 by Springer-Verlag.)
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Why is there such variability in mLV retraining re-
sponses? How does age affect mLV retraining? Inadequate
myocardial perfusion in the presence of sudden increased
cardiac work during PAB and induced myocardial hyper-
trophy is a probable culprit. In fetuses and immature ani-
mals the coronary reserve is normal in the presence of
pressure-induced hypertrophy.15-18 Adult hearts, however,
have less myocardial perfusion reserve with hypertrophy
produced by an increase in afterload, resulting in myocar-
dial ischemia with acute stress.19,20 Reduced coronary flow
reserve is thought to be caused by a decrease in capillary
density,21 a relative decrease in large-caliber coronary ar-
teries,22 and/or obstruction of intramural coronary arteries
caused by an increase in extravascular pressures.21 Further-
more, coronary anatomy other than Yacoub type A and D,
including single, intramural, and multiple coronary ostia,
seem to be associated with ischemia-related cardiac failure
and death after ASO and atrial reseptation. An acute in-
crease in afterload during retraining in older patients can
therefore cause ischemic changes that contribute to mLV
failure. The Birmingham group has performed mLV biop-
sies before and after retraining to determine whether there is
evidence of ischemic damage or fibrosis of the mLV, opting
for transplantation if fibrosis was present.22 We have instead
used T2-weighted MRI to locate myocardial edema caused
by ischemia after PAB, which we believe is the precursor to
fibrosis. An MRI is performed 1 week after PAB. If myo-
cardial edema is identified and if there is evidence of LV
dysfunction, the pulmonary artery band is loosened imme-
diately. We are in the process of trying to correlate MRI
findings with histology of explanted hearts and autopsy
findings to validate this imaging tool.
On the basis of our data, the mLV retraining protocol can
be offered as part of a 2-tiered treatment program with
cardiac transplantation. ASO and atrial reseptation should
be reserved for those with no identified risk factors, partic-
ularly adolescents and young adults. In addition to patients
with coronary anomalies and signs of myocardial ischemia,
patients with mLVPs that are less than systemic and atrial
arrhythmias are not candidates for anatomic correction.
Atrial arrhythmias have, however, been addressed at ana-
tomic correction with cryoablation techniques, with some
success in 2 patients in a recent publication by Mavroudis
and Backer.10
The small number of patients in our study precludes
statistical analysis of the relative contributions of the ana-
tomic variants and hemodynamic parameters on the re-
sponse to the various steps of the protocol. All but one
patient in this study was cared for by the senior author in
both institutions, therefore limiting interhospital variation.
In conclusion, the age of patients undergoing Mustard
and Senning procedures who present with mRV failure will
be increasing, as seen in our cohort, with the patient popu-
lation at the RCH being younger (median, 9.2 years; range,
0.6-16.1 years) in comparison with the more recent patients
treated at the CCF (median, 13.9 years; range, 2.1-24 years;
P  .007). The prevalence of mRV failure will probably
increase as more and more patients reach their third decade.
mLV reconditioning and anatomic correction is an alterna-
tive to cardiac transplantation in selected patients, with
good long-term results.
The response to mLV reconditioning past adolescence is
inconsistent. Although anecdotal reports of successful ASO
and reseptation have been reported in adults, on the basis of
our data, this should be done on a highly selected basis. A
clear cutoff age was not identified in our study. The pres-
ence of complex coronary anatomy, severe mRV failure,
and supraventricular arrhythmias are associated with a de-
creased conversion rate, decreased survival, or both, and
thus transplantation, as a primary treatment modality,
should be considered in these patients.
PAB, as a sole treatment modality, can improve mRV
function and reduce TR, thus acting as a bridge to trans-
plantation.
The results of ASO and reseptation and other conven-
tional therapies, including cardiac transplantation, are im-
perfect, and other therapeutic modalities need to be devel-
oped. Adjuncts that stimulate mLV hypertrophy (ie, genetic
modulation or myocyte transplantation) and angiogenesis
(ie, angiogenic growth factors) are now being developed
and will possibly improve the retraining response.
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Discussion
Dr Constantine Mavroudis (Chicago, Ill). Drs Poirier and Mee
and their colleagues have presented their cumulative experience
with left ventricular retraining for the purpose of converting trans-
position patients with failed atrial baffle operations to arterial
switch. The idea, of course, is to resuscitate the left ventricle as the
systemic pumping chamber, resulting in long-term benefit and
survival. Notably, this is the largest existing clinical experience
with this operative paradigm. Roger Mee and his group have
pioneered this approach and now present an analysis with enough
patients to perform meaningful comparisons and trends. Congrat-
ulations, Dr Poirier, on a beautiful and excellent presentation.
Our experience with this approach is limited to 11 patients, and
it mirrors the outcomes that have been presented today. We also
found that atrial arrhythmias have been troubling. Because of this,
we performed concomitant atrial arrhythmia surgery in 2 patients,
which resulted in arrhythmia ablation in both. One patient did well,
and the other died from left ventricular failure caused by unrec-
ognized poor left ventricular preparation. We did not believe that
the small addition of the atrial arrhythmia surgery participated in
the death of this patient. Did you consider adding arrhythmia
surgery to your protocol, which might address this formidable
issue that you have raised?
In your article you mentioned that the Birmingham group in the
United Kingdom has instituted left ventricular biopsies at the time
of PAB to help them decide between transplantation and arterial
switch. What do you believe is the efficacy of this procedure, and
are you planning to institute this in your program?
This is a significant contribution. I would like to congratulate
the authors, and I would like to thank the Association for the
privilege of discussing this article.
Dr Poirier. Thank you, Dr Mavroudis, for your pertinent
questions. Our study has shown that the patients with atrial ar-
rhythmias were less likely to successfully complete the retraining
protocol and thus less likely to undergo anatomic correction.
Anatomic correction, particularly in the older patients, has a high
operative risk and is technically challenging. The additional pro-
cedure should probably be avoided. We believe that patients with
atrial arrhythmia are probably best served with transplantation.
Myocardial biopsies are an interesting tool and can potentially
identify which patients respond favorably to mLV retraining and
are more likely to tolerate anatomic correction. We have instead
used T2-weighted MRI to locate myocardial edema caused by
ischemia after PAB, which we believe is the precursor to fibrosis.
An MRI is performed 1 week after PAB. If myocardial edema is
identified, and if there is evidence of LV dysfunction, the pulmo-
nary artery band is loosened immediately. We are in the process of
trying to correlate MRI findings with histology of explanted hearts
and autopsy findings to validate this imaging tool.
Dr Charles D. Fraser (Houston, Tex). We have had limited
experience with this population of patients as well. The one prob-
lem that we have struggled with is the dilation of the pulmonary
artery, which will become the neoaorta during the period of band-
ing, and I wonder if you could offer some specific tricks on how
to deal with that.
Dr Poirier. There are 3 long-term survivors in our cohort of
patients who had a dilated neoaorta. Other authors, including Dr
Mavroudis, have also reported this. Subjecting the neoaorta to high
pressures during PAB might play a part in this dilation; however,
dilation does not appear in all patients who have undergone initial
left ventricular retraining. We did notice that patients who required
a pulmonary valve repair at anatomic correction were more likely
to dilate. Possibly medial necrosis plays a part in this dilation, as
in other congenital anomalies. We have yet to come up with any
tricks to avoid this complication.
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